Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Sales | 50 | 42 | -2 | 74 | 247 |
| Cost of Goods | 46 | 54 | 23 | 79 | 117 |
| Gross Profit | 4 | -12 | -25 | -5 | 130 |
| Operating Expenses | 20,710 | 23,296 | 18,979 | 19,929 | 19,974 |
| Operating Income | -20,660 | -23,254 | -18,981 | -19,855 | -19,727 |
| Other Income | 1,200 | 1,441 | 1,650 | 1,862 | 1,899 |
| Pre-tax Income | -19,460 | -21,813 | -17,331 | -17,993 | -17,828 |
| Net Income Continuous | -19,460 | -21,813 | -17,331 | -17,993 | -17,828 |
| Net Income | $-19,460 | $-21,813 | $-18,347 | $-17,993 | $-17,828 |
| EPS Basic Total Ops | -0.45 | -0.50 | -0.42 | -0.42 | -0.41 |
| EPS Basic Continuous Ops | -0.45 | -0.50 | -0.40 | -0.42 | -0.41 |
| EPS Diluted Total Ops | -0.45 | -0.50 | -0.42 | -0.42 | -0.41 |
| EPS Diluted Continuous Ops | -0.45 | -0.50 | -0.40 | -0.42 | -0.41 |
| EBITDA(a) | $-20,625 | $-23,205 | $-18,976 | $-19,804 | $-19,659 |